Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Micellar Formulation Study A 2026 randomised crossover pilot involving 14 healthy adults compared a proprietary micellar formulation with standard and liposomal preparations
The two protocols address different systems and can run concurrently
Features and Benefits: 1 mg of Folic Acid to Support Healthy Fetal Development*
Results from an initial Phase III trial in December also did not meet expectations, which triggered a 19% decline in Novos share price
Individuals most likely to benefit include: Those with pernicious anemia People with gastrointestinal disorders (e.g., Crohns disease, celiac disease, chronic gastritis) Patients following bariatric (weight loss) surgery Older adults with absorption difficulties Strict vegetarians or vegans at risk for deficiency People taking medications that can decrease vitamin B12 levels Laboratory testing usually confirms B12 deficiency before starting injections
US$ 27.92
US$ 21.95
US$ 29.17
US$ 21.33
US$ 20.30
US$ 24.71
